{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:31:03Z","timestamp":1764873063597,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.clon.2009.01.013","type":"journal-article","created":{"date-parts":[[2009,2,28]],"date-time":"2009-02-28T04:45:53Z","timestamp":1235796353000},"page":"336-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Change in Urinary Markers of Osteoclast Activity Following Palliative Radiotherapy for Bone Metastases"],"prefix":"10.1016","volume":"21","author":[{"given":"E.","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Danjoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Vieth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2009.01.013_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","article-title":"Palliative radiotherapy trials for bone metastases: a systematic review","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.01.013_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.2002.20.3.850","article-title":"Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status","volume":"20","author":"Costa","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.01.013_bib3","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0959-8049(98)00277-9","article-title":"Markers of bone resorption in patients treated with pamidronate","volume":"34","author":"Lipton","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2009.01.013_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/bjc.1996.210","article-title":"Metabolic effects of pamidronate in patients with metastatic bone disease","volume":"73","author":"Vinholes","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2009.01.013_bib5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1023\/A:1008238422151","article-title":"Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease","volume":"8","author":"Vinholes","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2009.01.013_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1200\/JCO.1997.15.1.131","article-title":"Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy","volume":"15","author":"Vinholes","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.01.013_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","article-title":"8Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up","volume":"52","author":"Bone Pain Trial Working Party","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.01.013_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-6009(08)80116-X","article-title":"Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample relationships between 24-h and fasting early morning urine concentrations","volume":"21","author":"Abbiati","year":"1993","journal-title":"Bone Miner"},{"key":"10.1016\/j.clon.2009.01.013_bib9","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(00)02144-9","article-title":"Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity","volume":"355","author":"Hoskin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.01.013_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-8140(02)00170-6","article-title":"International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases","volume":"64","author":"Chow","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.01.013_bib11","series-title":"Design and analysis of clinical trials, concepts and methodologies","first-page":"434","article-title":"Sample size determination","author":"Chow","year":"1998"},{"key":"10.1016\/j.clon.2009.01.013_bib12","first-page":"553","article-title":"Urine calcium and deoxypyridinoline in assessment of response to local radiation therapy for metastatic bone disease","volume":"26","author":"Topkan","year":"2007","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.clon.2009.01.013_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clon.2007.09.009","article-title":"When should we define the response rates in the treatment of bone metastases by palliative radiotherapy?","volume":"20","author":"Li","year":"2008","journal-title":"Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:34:36Z","timestamp":1760542476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655509000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0936655509000417"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2009.01.013","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in Urinary Markers of Osteoclast Activity Following Palliative Radiotherapy for Bone Metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2009.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}